Kim TM - Search Results

1

Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.

Kim H, Chae KJ, Yoon SH, Kim M, Keam B, Kim TM, Kim DW, Goo JM, Park CM. Kim H, et al. Among authors: kim dw, kim m, kim tm. Eur Radiol. 2018 Feb;28(2):861-868. doi: 10.1007/s00330-017-5006-6. Epub 2017 Aug 7. Eur Radiol. 2018. PMID: 28786010

2

Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.

Lee JJ, Kim TM, Yu SJ, Kim DW, Joh YH, Oh DY, Kwon JH, Kim TY, Heo DS, Bang YJ, Kim NK. Lee JJ, et al. Among authors: kim dw, kim ty, kim tm, kim nk. Jpn J Clin Oncol. 2004 Jul;34(7):400-4. doi: 10.1093/jjco/hyh068. Jpn J Clin Oncol. 2004. PMID: 15342667 Clinical Trial.

3

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, Chang KH, Kim NK. Kim TM, et al. Among authors: kim dw, kim cw, kim ty, kim nk, kim jh. Blood. 2005 Dec 1;106(12):3785-90. doi: 10.1182/blood-2005-05-2056. Epub 2005 Aug 18. Blood. 2005. PMID: 16109779 Free article.

4

Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies.

Kim I, Yoon SS, Lee KH, Keam B, Kim TM, Kim JS, Kim HG, Oh MD, Han KS, Park MH, Park S, Kim BK. Kim I, et al. Among authors: kim hg, kim tm, kim js, kim bk. Clin Transplant. 2006 Jul-Aug;20(4):496-503. doi: 10.1111/j.1399-0012.2006.00512.x. Clin Transplant. 2006. PMID: 16842528 Clinical Trial.

5

Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.

Kim YJ, Kim MA, Im SA, Kim TM, Kim DW, Yang HK, Heo DS, Lee KU, Choe KJ, Kim NK, Kim TY, Kim WH, Bang YJ. Kim YJ, et al. Among authors: kim wh, kim dw, kim ma, kim ty, kim tm, kim nk. Cancer Invest. 2008 Mar;26(2):152-8. doi: 10.1080/07357900701518909. Cancer Invest. 2008. PMID: 18259945

6

First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors.

Kim TM, Kim KH, Lee MJ, Jeon YK, Lee SH, Kim DW, Kim CW, Kim IH, Khwarg SI, Heo DS. Kim TM, et al. Among authors: kim ih, kim dw, kim cw, kim kh. Cancer Sci. 2010 May;101(5):1199-203. doi: 10.1111/j.1349-7006.2010.01502.x. Epub 2010 Jan 19. Cancer Sci. 2010. PMID: 20345477 Free article.

7

Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.

Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM, Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW. Kim IH, et al. Among authors: kim yj, kim dw, kim dg, kim cy, kim ia, kim tm, kim je, kim jh. J Neurooncol. 2011 Jul;103(3):595-602. doi: 10.1007/s11060-010-0427-y. Epub 2010 Nov 4. J Neurooncol. 2011. PMID: 21052775 Clinical Trial.

8

EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma.

Koh Y, Jang B, Jeon YK, Kim TM, Lee SH, Kim DW, Chung DH, Kim YT, Kim YW, Heo DS. Koh Y, et al. Among authors: kim dw, kim tm, kim yt, kim yw. Jpn J Clin Oncol. 2011 Apr;41(4):548-54. doi: 10.1093/jjco/hyq248. Epub 2011 Jan 19. Jpn J Clin Oncol. 2011. PMID: 21247966

9

Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.

Koh Y, Kim DW, Kim TM, Lee SH, Jeon YK, Chung DH, Kim YW, Heo DS, Kim WH, Bang YJ. Koh Y, et al. Among authors: kim wh, kim dw, kim tm, kim yw. J Thorac Oncol. 2011 May;6(5):905-12. doi: 10.1097/JTO.0b013e3182111461. J Thorac Oncol. 2011. PMID: 21358343 Free article.

10

Clinical dissection of multicentric Castleman disease.

Shin DY, Jeon YK, Hong YS, Kim TM, Lee SH, Kim DW, Kim I, Yoon SS, Heo DS, Park S, Kim BK. Shin DY, et al. Among authors: kim dw, kim tm, kim bk, kim i. Leuk Lymphoma. 2011 Aug;52(8):1517-22. doi: 10.3109/10428194.2011.574759. Epub 2011 May 17. Leuk Lymphoma. 2011. PMID: 21585280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

671 results

Search Page